COVID-19 in the employees of healthcare facilities: characteristics of clinical manifestations in the acute and convalescence periods


DOI: https://dx.doi.org/10.18565/epidem.2021.11.4.25-30

Platonova T.A., Golubkova A.A., Smirnova S.S.

1) European Medical Center «Ural Mining and Metallurgical Company (UMMC)-Health», Yekaterinburg, Russia; 2) Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; 3) Yekaterinburg Research Institute of Viral Infections, State Research Center of Virology and Biotechnology «Vector», Yekaterinburg, Russia; 4) Ural State Medical University, Ministry of Health of Russia, Yekaterinburg, Russia
Objective. To analyze the clinical manifestations of the novel coronavirus infection in healthcare workers and to assess its short and long term health consequences.
Materials and methods. The investigation enrolled 238 healthcare workers who had been ill with COVID-19 in 2020. The investigation used the online questionnaire designed by the authors on the basis of Google electronic services, which had been distributed to the employees of healthcare facilities via corporate email or WhatsApp messenger.
Results. The disease ran as mild or moderate acute respiratory infection in 178 (74.8%) employees and as interstitial pneumonia in 52 (21.8%); clinical manifestations were absent in 8 (3.4%). Among the clinical symptoms of the disease, there was most commonly weakness; fever; loss of sense of smell (anosmia); impaired nasal airflow and seromucous nasal discharge; muscle and joint pains; headache; mostly dry cough; loss of sense of taste (ageusia); sore throat; ophthalmalgia; dizziness; a feeling of chest compression; dyspnea; dyspeptic manifestations as diarrhea, nausea or vomiting. Many respondents reported that a number of symptoms had persisted fairly long after relief of the main manifestations of coronavirus infection (on average for less than 3 months, as well as for less than 5 months after the disease).
Conclusion. There is evidence for the main clinical manifestations of the novel coronavirus infection in healthcare workers, their severity and duration, as well as the consequences of the disease for the health of those who have been ill, which can be used in the development of rehabilitation programs for people who have experienced varying degrees of COVID-19.

Literature


1. Брико Н.И., Каграманян И.Н., Никифоров В.В., Суранова Т.Г., Чернявская О.П., Полежаева Н.А. Пандемия COVID-19. Меры борьбы с ее распространением в Российской Федерации. Эпидемиология и вакцинопрофилактика 2020; 19(2): 4–12. https://doi.org/10.31631/2073-3046-2020-19-2-4-12


Briko N.I., Kagramanyan I.N., Nikiforov V.V., Suranova T.G., Chernyavskaya O.Р., Polezhaeva N.A. [Pandemic COVID-19. Prevention Measures in the Russian Federation]. Epidemiology and Vaccinal Prevention 2020; 19(2): 4–12. (In Russ.). https://doi.org/10.31631/2073-3046-2020-19-2-4-12.


2. Щелканов М.Ю., Колобухина Л.В., Бургасова О.А., Кружкова И.С., Малеев В.В. COVID-19: этиология, клиника, лечение. Инфекция и иммунитет 2020; 10(3): 421–45. doi: 10.15789/2220-7619- CEC-1473


Shchelkanov M.Yu., Kolobukhina L.V., Burgasova O.A., Kruzhkova I.S., Maleev V.V. [COVID-19: etiology, clinical picture, treatment]. Infektsiya i immunitet 2020; 10(3): 421–45. (In Russ.). doi: 10.15789/2220-7619-CEC-1473


3. Коронавирус. Онлайн-карта распространения коронавирусной инфекции [Электронный ресурс]. https://coronavirus-monitor.ru/


[The coronavirus. Online map of the spread of coronavirus infection [Electronic resource]. (In Russ.). https://coronavirus-monitor.ru/


4. Коронавирус. Онлайн-карта коронавирусной инфекции. Статистика [Электронный ресурс]. https://coronavirus-monitor.info/


[The coronavirus. Online map of coronavirus infection. Statistics [Electronic resource]. (In Russ.). https://coronavirus-monitor.info/


5. Chowdhury M.A., Hossain N., Kashem M.A., Shahid M.A., Alam A. Immune response in COVID-19: A review. J. Infec. Public Health 2020; 13(11): 1619–29. doi: 10.1016/j.jiph.2020.07.001


6. Hunter E., Price D.A., Murphy E., van der Loeff I.S., Baker K.F., Lendrem D. et al. First experience of COVID-19 screening of health-care workers in England. Lancet 2020; 395(10234): e77–e78. doi: 10.1016/S0140-6736(20)30970-3


7. Ahn D.G., Shin H.J., Kim M.H., Lee S., Kim H.S., Myoung J. et al. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). J. Microbiol. Biotechnol. 2020; 30(3): 313–24. doi: 10.4014/jmb.2003.03011


8. Chakraborty C., Sharma A.R., Sharma G., Bhattacharya M., Lee S.S. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Eur. Rev. Med. Pharmacol. Sci. 2020; 24(7): 4016–26. doi: 10.26355/eurrev_202004_20871


9. Jin Y., Yang H., Ji W., Wu W., Chen S., Zhang W., Duan G. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses 2020; 12(4): 372. doi: 10.3390/v12040372


10. Kang H., Wang Y., Tong Z., Liu X. Retest positive for SARS-CoV-2 RNA of «recovered» patients with COVID-19: Persistence, sampling issues, or re-infection? J. Med. Virol. 2020; 92(11): 2263–5. doi: 10.1002/jmv.26114


11. Liu X., Liu C., Liu G., Luo W., Xia N. COVID-19: Progress in diagnostics, therapy and vaccination. Theranostics 2020; 10(17): 7821–35. doi: 10.7150/thno.47987


12. Zhang J.J., Dong X., Cao Y.Y., Yuan Y.D., Yang Y.B., Yan Y.Q. et al. Clinical characteristics of 80 hospitalized frontline medical workers infected with COVID-19 in Wuhan, China. J. Hospital Infec. 2020; 105(3): 399–403. DOI: 10.1016/j.jhin.2020.04.019


13. Jiang F., Deng L., Zhang L., Cai Y., Cheung C.W., Xia Z. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). J. Gen. Intern. Med. 2020; 35(5): 1545–9. doi: 10.1007/s11606-020-05762-w


14. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497–506. doi: 10.1016/S0140-6736(20)30183-5


15. Villapol S. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Transl. Res. 2020; 226: 57–69. doi: 10.1016/j.trsl. 2020.08.004


16. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020; 323(11): 1061–9. doi: 10.1001/jama.2020.1585


17. Orozco-Hernаndez J.P., Marin-Medina D.S., Sаnchez-Duque J.A. Neurological manifestations of SARS-CoV-2 infection. Semergen 2020; 46(1): 106–8. doi: 10.1016/j.semerg.2020.05.004


18. Bohlken J., Schоmig F., Lemke M.R., Pumberger M., Riedel-Heller S.G. COVID-19 Pandemic: Stress Experience of Healthcare Workers – A Short Current Review. Psychiatr. Prax 2020; 47(4): 190–7. doi: 10.1055/a-1159-5551


19. Sahebi A., Nejati B., Moayedi S., Yousefi K., Torres M., Golitaleb M. The prevalence of anxiety and depression among healthcare workers during the COVID-19 pandemic: An umbrella review of meta-analyses. Prog. Neuropsychopharmacol. Biol. Psychiatry 2021; 18: 110247. doi: 10.1016/j.pnpbp.2021.110247


20. Barello S., Palamenghi L., Graffigna G. Burnout and somatic symptoms among frontline healthcare professionals at the peak of the Italian COVID-19 pandemic. Psychiatry Res. 2020; 290: 113129. doi: 10.1016/j.psychres.2020.113129


21. Suryavanshi N., Kadam A., Dhumal G., Nimkar S., Mave V., Gupta A. et al. Mental health and quality of life among healthcare professionals during the COVID-19 pandemic in India. Brain Behav. 2020; 10(11): e01837. doi: 10.1002/brb3.1837


22. Del Turco S., Vianello A., Ragusa R., Caselli C., Basta G. COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge? Thromb. Res. 2020; 196: 143–51. doi: 10.1016/j.thromres. 2020.08.039


23. Cherian R., Poh K.K. At the «heart» of the COVID-19 outbreak: early cardiac implications and mitigating strategies. Singapore Med. J. 2020; 61(7): 373–4. doi: 10.11622/smedj.2020042


24. Jarrahi A., Ahluwalia M., Khodadadi H., da Silva Lopes Salles E., Kolhe R., Hess D.C. et al. Neurological consequences of COVID-19: what have we learned and where do we go from here? J. Neuroinflammation 2020; 17(1): 286. doi: 10.1186/s12974-020-01957-4


25. Fiorillo A., Gorwood P. The consequences of the COVID-19 pandemic on mental health and implications for clinical practice. Eur. Psychiatry 2020; 63(1): e32. doi: 10.1192/j.eurpsy.2020.35


26. Vindegaard N., Benros M.E. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav. Immun. 2020; 89: 531–42. doi: 10.1016/j.bbi.2020.05.048


About the Autors


Tatyana A. Platonova, Cand. Med. Sci., Epidemiologist, Нead, Epidemiological Department, European medical center «UMMC-Health», Yekaterinburg, Russia; fill.1990@inbox.ru; http://orcid.org/ 0000-0001-5441-854X
Professor Alla A. Golubkova, MD, Leading Researcher, Laboratory of Infections Associated with the Provision of Medical Care, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; allagolubkova@yandex.ru; http://orcid.org/0000-0003-4812-2165
Svetlana S. Smirnova, Cand. Med. Sci.; Head, Ural Siberian Research and Guidance Center for the Prevention of Healthcare-Associated Infections, Yekaterinburg Research Institute of Viral Infections, State Research Center of Virology and Biotechnology «Vector», Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; Associate Professor, Department of Epidemiology, Social Hygiene, and Organization of the State Sanitary and Epidemiological Service, Ural State Medical University, Ministry of Health of Russia, Yekaterinburg, Russia; smirnova_ss69@mail.ru; http://orcid.org/0000-0002-9749-4611


Similar Articles


Бионика Медиа